Residual ctDNA after treatment predicts early relapse in patients with early stage non-small cell lung cancer | NeoGenomics Laboratories

Publication date

Fri, 06/04/2021 - 12:00

Category

Year

Subtitle

ASCO 2021

File

21_ASCO_8517_Davina_Gale_slides.pdf (749.03 KB)

Division